<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants - Shah, SS - 2017 | Cochrane Library</title> <meta content="Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants - Shah, SS - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002057.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants - Shah, SS - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002057.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002057.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants" name="citation_title"/> <meta content="Sachin S Shah" name="citation_author"/> <meta content="Surya Hospital for Women and Children" name="citation_author_institution"/> <meta content="Arne Ohlsson&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Henry L Halliday" name="citation_author"/> <meta content="Retired Honorary Professor of Child Health, Queen's University Belfast" name="citation_author_institution"/> <meta content="Vibhuti S Shah" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="vshah@mtsinai.on.ca" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD002057.pub4" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/10/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002057.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002057.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002057.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Infant, Very Low Birth Weight; *Respiration, Artificial; Administration, Inhalation; Beclomethasone [administration &amp; dosage]; Bronchopulmonary Dysplasia [*drug therapy, mortality]; Chronic Disease; Dexamethasone [administration &amp; dosage]; Glucocorticoids [*administration &amp; dosage]; Infant, Premature; Randomized Controlled Trials as Topic; Respiratory System Agents [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002057.pub4&amp;doi=10.1002/14651858.CD002057.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="uYcNEb5O";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002057\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002057\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","zh_HANS","fa","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002057.pub4",title:"Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants",firstPublishedDate:"Oct 16, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002057.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002057.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002057.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002057.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002057.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002057.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002057.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002057.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002057.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002057.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3340 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002057.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0124"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0037"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0063"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-sec-0118"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/appendices#CD002057-sec-0129"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/table_n/CD002057StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/table_n/CD002057StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#CD002057-cr-0002">Sachin S Shah</a></li> <li class="author custom-tooltip" title="Deceased"><a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#CD002057-cr-0003">Arne Ohlsson</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#CD002057-cr-0004">Henry L Halliday</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information#CD002057-cr-0005"><i class="icon corresponding-author fa fa-envelope"></i>Vibhuti S Shah</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information/en#CD002057-sec-0136">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 October 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002057.pub4">https://doi.org/10.1002/14651858.CD002057.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002057-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002057-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002057-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002057-abs-0001" lang="en"> <section id="CD002057-sec-0001"> <h3 class="title" id="CD002057-sec-0001">Background</h3> <p>This is an update of a review published in 2012. A related review "Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates" has been updated as well. Bronchopulmonary dysplasia (BPD) is a serious and common problem among very low birth weight infants, despite the use of antenatal steroids and postnatal surfactant therapy to decrease the incidence and severity of respiratory distress syndrome. Due to their anti‐inflammatory properties, corticosteroids have been widely used to treat or prevent BPD. However, the use of systemic steroids has been associated with serious short‐ and long‐term adverse effects. Administration of corticosteroids topically through the respiratory tract may result in beneficial effects on the pulmonary system with fewer undesirable systemic side effects. </p> </section> <section id="CD002057-sec-0002"> <h3 class="title" id="CD002057-sec-0002">Objectives</h3> <p>To compare the effectiveness of inhaled versus systemic corticosteroids administered to ventilator‐dependent preterm neonates with birth weight ≤ 1500 g or gestational age ≤ 32 weeks after 7 days of life on the incidence of death or BPD at 36 weeks' postmenstrual age. </p> </section> <section id="CD002057-sec-0003"> <h3 class="title" id="CD002057-sec-0003">Search methods</h3> <p>We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 1), MEDLINE via PubMed (1966 to 23 February 2017), Embase (1980 to 23 February 2017), and CINAHL (1982 to 23 February 2017). We also searched clinical trials registers, conference proceedings and the reference lists of retrieved articles for randomised controlled trials and quasi‐randomised trials<b>.</b> </p> </section> <section id="CD002057-sec-0004"> <h3 class="title" id="CD002057-sec-0004">Selection criteria</h3> <p>Randomised or quasi‐randomised controlled trials comparing inhaled versus systemic corticosteroid therapy (irrespective of dose and duration) starting after the first week of life in ventilator‐dependent very low birth weight infants. </p> </section> <section id="CD002057-sec-0005"> <h3 class="title" id="CD002057-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by the Cochrane Collaboration.</p> </section> <section id="CD002057-sec-0006"> <h3 class="title" id="CD002057-sec-0006">Main results</h3> <p>We included three trials that involved a total of 431 participants which compared inhaled versus systemic corticosteroids to treat BPD. No new trials were included for the 2017 update. </p> <p>Although one study randomised infants at &lt; 72 hours (N = 292), treatment started when infants were aged &gt; 15 days. In this larger study, deaths were included from the point of randomisation and before treatment started. Two studies (N = 139) randomised and started treatment at 12 to 21 days. </p> <p>Two trials reported non‐significant differences between groups for the primary outcome: incidence of death or BPD at 36 weeks' postmenstrual age among all randomised infants. Estimates for the largest trial were Relative risk (RR) 1.04 (95% Confidence interval (CI) 0.86 to 1.26), Risk difference (RD) 0.03 (95% CI ‐0.09 to 0.15); (moderate‐quality evidence). Estimates for the other trial reporting the primary outcome were RR 0.94 (95% CI 0.83 to 1.05), RD ‐0.06 (95% CI ‐0.17 to 0.05); (low‐quality evidence). </p> <p>Secondary outcomes that included data from all three trials showed no significant differences in the duration of mechanical ventilation or supplemental oxygen, length of hospital stay, or the incidence of hyperglycaemia, hypertension, necrotising enterocolitis, gastrointestinal bleed, retinopathy of prematurity or culture‐proven sepsis moderate‐ to low‐quality evidence). </p> <p>In a subset of 75 surviving infants who were enrolled from the United Kingdom and Ireland, there were no significant differences in developmental outcomes at seven years of age between groups (moderate‐quality evidence). One study received grant support and the industry provided aerochambers and metered dose inhalers of budesonide and placebo for the same study. No conflict of interest was identified. </p> </section> <section id="CD002057-sec-0007"> <h3 class="title" id="CD002057-sec-0007">Authors' conclusions</h3> <p>We found no evidence that inhaled corticosteroids confer net advantages over systemic corticosteroids in the management of ventilator‐dependent preterm infants. There was no evidence of difference in effectiveness or adverse event profiles for inhaled versus systemic steroids. </p> <p>A better delivery system guaranteeing selective delivery of inhaled steroids to the alveoli might result in beneficial clinical effects without increasing adverse events. </p> <p>To resolve this issue, studies are needed to identify the risk/benefit ratio of different delivery techniques and dosing schedules for administration of these medications. The long‐term effects of inhaled steroids, with particular attention to neurodevelopmental outcomes, should be addressed in future studies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002057-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002057-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD002057-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD002057-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002057-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002057-abs-0003" lang="en"> <h3>Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants </h3> <p><b>Review question</b> </p> <p>To compare the effectiveness of inhaled versus systemic corticosteroids administered to ventilator‐dependent preterm neonates with birth weight ≤ 1500 g or gestational age ≤ 32 weeks after 7 days of life on the incidence of chronic lung disease at 36 weeks' corrected postmenstrual age. </p> <p><b>Background</b> </p> <p>Preterm babies (babies born before term, 40 weeks pregnancy) often need breathing (ventilator) support. Babies who need invasive (placing a breathing tube in the wind pipe) mechanical breathing support for a prolonged period often develop bronchopulmonary dysplasia (defined as requirement for supplemental oxygen at 36 weeks' postmenstrual age). It is thought that inflammation in the lungs may be part of the cause. Corticosteroid drugs reduce inflammation and swelling in the lungs, but can have serious side effects. Corticosteroid use has been associated with cerebral palsy (motor problem) and developmental delay. Inhaling steroids, so that the drug reaches the lungs directly, has been tried as a way to limit adverse effects. </p> <p><b>Search date</b> </p> <p>23 February 2017.</p> <p><b>Study characteristics</b> </p> <p>All three included trials were randomised, but the blinding of intervention and outcome measurement varied. Data from two trials (enrolling 139 infants) were combined as they enrolled infants between 12 and 21 days of age, but data from one trial (enrolling 292 infants) were reported separately because researchers randomised infants aged less than 72 hours. The timing when the outcomes were measured varied among studies so it was not appropriate to combine some results. In one study all deaths that occurred were reported from the time babies were randomised not from when treatment started, hence there was a greater number of babies who died in that study. </p> <p>One study received grant support and the industry provided Aerochambers and metered dose inhalers of budesonide and placebo for the same study. No conflict of interest was identified. </p> <p><b>Key results</b> </p> <p>Evidence from two studies in 370 infants, who were randomised between 12 and 21 days of age and who contributed data to the primary outcome of this review, showed that inhaled steroids administered after 7 days of age compared with systemic steroids did not decrease the incidence of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age. Evidence from the single study in which infants were randomised at less than 72 hours of age did not show difference the incidence of death or BPD. </p> <p>Evidence from three studies in 431 infants contributing to secondary outcomes showed that inhaled steroids administered after seven days of age compared with systemic steroids did not significantly alter the incidence of BPD at 36 weeks' postmenstrual age, hyperglycaemia, hypertension, duration of ventilation, duration of oxygen supplementation, length of hospital stay, intraventricular haemorrhage grade III‐IV, periventricular leukomalacia, necrotising enterocolitis, gastrointestinal bleed, retinopathy of prematurity stage &gt; 3, culture‐proven sepsis or the incidence of adverse effects. </p> <p>Adverse event profiles did not differ for inhaled versus systemic steroids but some potential complications of steroid treatment have not been reported. More research is needed to show whether any form of routine use of steroids results in overall health improvements for babies at risk of bronchopulmonary dysplasia. </p> <p><b>Quality of the evidence</b> </p> <p>Evidence quality (according to GRADE criteria) was moderate to low.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002057-sec-0124" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-sec-0124">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-sec-0183">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002057-sec-0124"></div> <h3 class="title" id="CD002057-sec-0125">Implications for practice</h3> <section id="CD002057-sec-0125"> <p>This updated review of three trials of moderate to low quality found no evidence that inhaled corticosteroids confer net advantages over systemic corticosteroids in the management of ventilator‐dependent preterm infants. The lack of evidence leads to the conclusion that inhaled steroids cannot be recommended as part of standard practice. </p> </section> <h3 class="title" id="CD002057-sec-0126">Implications for research</h3> <section id="CD002057-sec-0126"> <p>To date, only three studies reporting on 431 infants have been published. The quality of the evidence based on GRADE was moderate to low. Larger high quality studies are needed to identify the effectiveness of inhaled steroids versus systemic steroids. The risk/benefit ratio of different delivery techniques and dosing schedules for the administration of steroids needs to be assessed. Studies are needed to address the long‐term effects of inhaled steroids, with particular attention to neurodevelopmental outcome. We are not aware of any ongoing trials. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD002057-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD002057-sec-0029"></div> <div class="table" id="CD002057-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> Neonatal intensive care unit </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death or BPD at 36 weeks' postmenstrual age</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.04 (95% CI 0.86 to 1.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>292 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for this single study was high. The study was not blinded at all sites. Only 35/150 infants randomised to systemic steroids received full course while 33/142 infants randomised to inhaled steroids received full course. Results were presented in intention to treat analyses including deaths occurring after 72 hours of age. We downgraded the quality of the evidence by one step.<br/> Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was acceptable</p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>606 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD</b> : Bronchopulmonary dysplasia; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD002057-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised between 12 and 21 days of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD (infants randomised between 12 and 21 days of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> Neonatal intensive care unit </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death or BPD at 36 weeks'</b> postmenstrual age </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94 (95% CI 0.83 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>78 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for this single study was high. There was no blinding of the intervention or outcome measurements. We downgraded the quality of the evidence by one level.<br/> Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was low as the sample size was small</p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>963 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>902 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD:</b> Bronchopulmonary dysplasia; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD002057-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> Neonatal intensive care unit </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>BPD at 36 weeks'</b> postmenstrual age </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.08 (95% CI 0.88 to 1.32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>429 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for these three studies was high. There was blinding of randomisation in all three studies. There was no blinding of the intervention or outcome measurements at all sites in the largest study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> there was blinding of the intervention but blinding of outcome assessment was unclear. In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> there was no blinding of the intervention or outcomes measurements. We downgraded the quality of the evidence by two levels.<br/> Heterogeneity/consistency: Heterogeneity was low (I² = 39%).<br/> Directness of the evidence: The studies were conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was high as the sample size was quite large. </p> <p>Presence of publication bias: N/A. We did not create a funnel plot as there were only three trials included in the analysis. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>422 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>485 per 1000<br/> (394 to 776) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hyperglycaemia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86 (95% CI 0.61 to 1.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>429 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for these three studies was high. There was blinding of randomisation in all three studies. There was no blinding of the intervention or outcome measurements at all sites in the largest study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> there was blinding of the intervention but blinding of outcome assessments was unclear. In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> there was no blinding of the intervention or outcome measurements. We downgraded the quality of the evidence by two levels. </p> <p>Heterogeneity/consistency: There was no heterogeneity (I² = 8%).<br/> Directness of the evidence: The studies were conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was high as the sample size was quite large. </p> <p>Presence of publication bias: N/A. We did not create a funnel plot as there were only three trials included in the analysis. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>177 per 1000<br/> (0 to 282) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypertension</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR (RR 0.86, 95% CI 0.73 to 1.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>429 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for these three studies was high. There was blinding of randomisation in all three studies. There was no blinding of the intervention or outcome measurements at all sites in the largest study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> there was blinding of the intervention but blinding of outcome assessments was unclear. In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> there was no blinding of the intervention or outcome measurements. We downgraded the quality of the evidence by two steps. </p> <p>Heterogeneity/consistency: There was no heterogeneity (I² = 0%).<br/> Directness of the evidence: The studies were conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was high as the sample size was quite large. </p> <p>Presence of publication bias: N/A. We did not create a funnel plot as there were only three trials included in the analysis. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>604 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>430 per 1000<br/> (130 to 627) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD:</b> Bronchopulmonary dysplasia; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD002057-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD ‐ long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD ‐ long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> NICU </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General conceptual ability (GCA) score at 7 years</b> </p> <p>The test has a standardisation mean of 100 and SD of 15</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean GCA score in the control group was 90.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean GCA score in the intervention groups was 3.4 units lower</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐3.40 (95% CI ‐12.38 to 5.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the Quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Moderate/severe disability at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.40 (95% CI 0.49 to 4.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the Quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or moderate/severe disability at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>418 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>423 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.01 (95% CI 0.65 to 1.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the Quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Systolic blood pressure &gt; 95th percentile at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>353 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>194 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.55 (95% CI 0.25 to 1.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diastolic blood pressure &gt; 95th percentile at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>121 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>167 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR (1.38, 95% CI 0.43 to 4.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ever diagnosed as asthmatic by 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>528 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>459 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.87 (95% CI 0.55 to 1.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD:</b> Bronchopulmonary dysplasia; <b>NICU:</b> Neonatal intensive care unit; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002057-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-sec-0144">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD002057-sec-0030"></div> <section id="CD002057-sec-0031"> <h3 class="title" id="CD002057-sec-0031">Description of the condition</h3> <p>Bronchopulmonary dysplasia (BPD) is a serious and common problem among very low birth weight infants despite the use of antenatal steroids (<a href="./references#CD002057-bbs2-0043" title="RobertsD , BrownJ , MedleyN , DalzielS . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD004454.pub3] ">Roberts 2017</a>) and postnatal surfactant therapy (<a href="./references#CD002057-bbs2-0052" title="SollRF . Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews1998, Issue 3. [DOI: 10.1002/14651858.CD001149] ">Soll 1998</a>; <a href="./references#CD002057-bbs2-0009" title="BahadueFL , SollR . Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews2012, Issue 11. [DOI: 10.1002/14651858.CD001456.pub2] ">Bahadue 2012</a>) to decrease the incidence and severity of respiratory distress syndrome. The incidence of BPD varies between 23% and 26% (<a href="./references#CD002057-bbs2-0032" title="LeeSK , McMillanDD , OhlssonA , PendrayM , SynnesA , WhyteR , et al. Variations in practice and outcomes in the Canadian NICU Network: 1996‐1997. Pediatrics2000;106(5):1070‐9. ">Lee 2000</a>; <a href="./references#CD002057-bbs2-0033" title="LemonsJA , BauerCR , OhW , KoronesSB , PapileLA , StollBJ , et al. Very low birth weight outcomes of National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics2001;107(1):E1. ">Lemons 2001</a>) in very low birth weight infants (&lt; 1500 g) and has an inverse relationship to both gestational age and birth weight (<a href="./references#CD002057-bbs2-0032" title="LeeSK , McMillanDD , OhlssonA , PendrayM , SynnesA , WhyteR , et al. Variations in practice and outcomes in the Canadian NICU Network: 1996‐1997. Pediatrics2000;106(5):1070‐9. ">Lee 2000</a>; <a href="./references#CD002057-bbs2-0051" title="SinkinRA , CoxC , PhelpsDL . Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics1990;86(5):728‐36. ">Sinkin 1990</a>). </p> </section> <section id="CD002057-sec-0032"> <h3 class="title" id="CD002057-sec-0032">Description of the intervention</h3> <p>Several randomised controlled trials (<a href="./references#CD002057-bbs2-0008" title="AveryGB , FletcherAB , KaplanM , BrudnoDS . Controlled trial of dexamethasone in respirator‐dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75(1):106‐11. ">Avery 1985</a>; <a href="./references#CD002057-bbs2-0013" title="Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo controlled trial. Pediatrics1991;88(3):421‐7. ">CDTG 1991</a>; <a href="./references#CD002057-bbs2-0014" title="CummingsJJ , D'EugenioDB , GrossSJ . A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine1989;320(23):1505‐10. ">Cummings 1989</a>; <a href="./references#CD002057-bbs2-0024" title="HarkavyKL , ScanlonJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator‐and‐oxygen‐ dependent infants: a controlled trial. Journal of Pediatrics1989;115(6):979‐83. ">Harkavy 1989</a>; <a href="./references#CD002057-bbs2-0030" title="KazziNJ , BransYW , PolandRL . Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics1990;86(5):722‐7. ">Kazzi 1990</a>; <a href="./references#CD002057-bbs2-0038" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very‐low‐birth‐weight infants with ventilatory dependent chronic lung disease. Acta Paediatrica1992;81(10):751‐6. ">Ohlsson 1992</a>) and systematic reviews (<a href="./references#CD002057-bbs2-0012" title="BhutaT , OhlssonA . Systematic review and meta‐analysis of early postnatal dexamethasone for prevention of chronic lung disease. Archives of Disease in Childhood1998;79(1):26‐33. ">Bhuta 1998</a>; <a href="./references#CD002057-bbs2-0016" title="DoyleLW , HallidayHL , EhrenkranzRA . Early (&lt; 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001146.pub4] ">Doyle 2014</a>; <a href="./references#CD002057-bbs2-0017" title="DoyleLW , HallidayHL , EhrencranzRA . Late (&gt; 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001145.pub3] ">Doyle 2014a</a>; <a href="./references#CD002057-bbs2-0022" title="HallidayHL . Clinical trials of postnatal steroids: inhaled and systemic. Biology of the Neonate1999;76(Suppl 1):29‐40. ">Halliday 1999</a>; <a href="./references#CD002057-bbs2-0046" title="ShahV , OhlssonA . Postnatal dexamethasone in the prevention of chronic lung disease. In: DavidTJ editor(s). Recent Advances in Paediatrics. London, England: Churchill Livingstone, 2001:77‐96. ">Shah 2001</a>) have demonstrated that among infants with BPD, treatment with systemic corticosteroids facilitates extubation and improves respiratory system compliance. Marked heterogeneity regarding the dose and duration of dexamethasone administration has been noted among trials. However, corticosteroids appear to have little effect on the duration of supplemental oxygen, duration of hospitalisation or mortality (<a href="./references#CD002057-bbs2-0008" title="AveryGB , FletcherAB , KaplanM , BrudnoDS . Controlled trial of dexamethasone in respirator‐dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75(1):106‐11. ">Avery 1985</a>; <a href="./references#CD002057-bbs2-0013" title="Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo controlled trial. Pediatrics1991;88(3):421‐7. ">CDTG 1991</a>; <a href="./references#CD002057-bbs2-0024" title="HarkavyKL , ScanlonJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator‐and‐oxygen‐ dependent infants: a controlled trial. Journal of Pediatrics1989;115(6):979‐83. ">Harkavy 1989</a>; <a href="./references#CD002057-bbs2-0030" title="KazziNJ , BransYW , PolandRL . Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics1990;86(5):722‐7. ">Kazzi 1990</a>; <a href="./references#CD002057-bbs2-0038" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very‐low‐birth‐weight infants with ventilatory dependent chronic lung disease. Acta Paediatrica1992;81(10):751‐6. ">Ohlsson 1992</a>). There are concerns regarding the short‐ and long‐term side effects of systemic steroids in this population. These include hyperglycaemia, hypertension, hypertrophic cardiomyopathy, gastrointestinal haemorrhage and perforation, enhanced catabolism and growth failure, nephrocalcinosis, poor bone mineralization and susceptibility to infection (<a href="./references#CD002057-bbs2-0035" title="NgPC . The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Archives of Disease in Childhood1993;68(3 Spec No):330‐6. ">Ng 1993</a>; <a href="./references#CD002057-bbs2-0053" title="StarkAR , CarloWA , TysonJE , PapileLA , WrightLL , ShankaranEF , et al. Adverse effects of early dexamethasone treatment in extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine2001;344(2):95‐101. ">Stark 2001</a>). </p> <p>The potential effects on brain growth and neurodevelopment are most alarming. Animal models (rat and rhesus monkey) at a similar stage of ontogeny to the human fetus have shown that steroids permanently affect brain cell division, differentiation and myelination, as well as the ontogeny of cerebral cortical development (<a href="./references#CD002057-bbs2-0029" title="JohnsonJW , MitznerW , LondonWT , PalmerAE , ScottR . Betamethasone and the rhesus fetus: multisystemic effects. American Journal of Obstetrics and Gynecology1979;133(6):677‐84. ">Johnson 1979</a>; <a href="./references#CD002057-bbs2-0056" title="WeichselMEJr . The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Annals of Neurology1977;2(5):364‐6. ">Weichsel 1977</a>). These effects are long‐lasting and associated with decreased head circumference and neuromotor abnormalities. Several follow‐up studies of postnatal systemic corticosteroid therapy in preterm infants have shown higher incidence of neurodevelopmental abnormalities in surviving dexamethasone‐treated infants (<a href="./references#CD002057-bbs2-0037" title="O'SheaTM , KothadiaJM , KlinepeterKL , GoldsteinDJ , JacksonBG , WeaverRG3rd , et al. Randomized placebo‐controlled trial of a 42 day tapering course of dexamethasone to reduce the duration of ventilatory dependency in very low birth weight infants: outcomes of study participants at 1‐year adjusted age. Pediatrics1999;104(1 Pt 1):15‐21. ">O'Shea 1999</a>; <a href="./references#CD002057-bbs2-0049" title="ShinwellES , KarplusM , ReichD , WeintraubZ , BlaazerS , BaderD , et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Archives of Disease in Childhood Fetal Neonatal Edition2000;83(3):F177‐81. ">Shinwell 2000</a>; <a href="./references#CD002057-bbs2-0057" title="YehTF , LinYJ , HuangCC , ChenYJ , LinCH , LinHC , et al. Early dexamethasone therapy in preterm infants: a follow up study. Pediatrics1998;101(5):E7. ">Yeh 1998</a>). </p> <p>Theoretically, the use of inhaled corticosteroids may allow for beneficial effects on the pulmonary system without concomitant high systemic concentrations and less risk of adverse effects. Results from a large multicentre study of early use of inhaled steroids concluded that among extremely preterm infants, BPD incidence was lower among those who received early inhaled budesonide than among those who received placebo, but the advantage may have been gained at the expense of increased mortality (<a href="./references#CD002057-bbs2-0010" title="BasslerD , PlavkaR , ShinvellES , HallmanM , JarreauPH , CarnielliV , et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. New England Journal of Medicine2015;573(16):1497‐506. ">Bassler 2015</a>). Results from this study have been incorporated in a Cochrane Review (<a href="./references#CD002057-bbs2-0048" title="ShahVS , OhlssonA , HallidayHL , DunnM . Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD001969.pub4] ">Shah 2017</a>) and a meta‐analysis (<a href="./references#CD002057-bbs2-0050" title="ShinwellES , PortnovI , MeerpohlJJ , KarenT , BasslerD . Inhaled corticosteroids for bronchopulmonary dysplasia: A meta‐analysis. Pediatrics2016;138(6):e20162511. ">Shinwell 2016</a>). <a href="./references#CD002057-bbs2-0050" title="ShinwellES , PortnovI , MeerpohlJJ , KarenT , BasslerD . Inhaled corticosteroids for bronchopulmonary dysplasia: A meta‐analysis. Pediatrics2016;138(6):e20162511. ">Shinwell 2016</a> concluded that "Very preterm infants appear to benefit from inhaled corticosteroids with reduced risk for BPD and no effect on death, other morbidities, or adverse events. Data on long‐term respiratory, growth, and developmental outcomes are eagerly awaited". <a href="./references#CD002057-bbs2-0048" title="ShahVS , OhlssonA , HallidayHL , DunnM . Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD001969.pub4] ">Shah 2017</a> summarised their findings as: "There is increasing evidence from the trials reviewed that early administration of inhaled steroids to very low birth weight neonates is effective in reducing the incidence of death or CLD at 36 weeks' postmenstrual age among either all randomised infants or among survivors. Even though there is statistical significance, the clinical relevance is of question as the upper CI limit for the outcome of death or BPD at 36 weeks' postmenstrual age is infinity. The long‐term follow‐up results of the <a href="./references#CD002057-bbs2-0010" title="BasslerD , PlavkaR , ShinvellES , HallmanM , JarreauPH , CarnielliV , et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. New England Journal of Medicine2015;573(16):1497‐506. ">Bassler 2015</a> study may affect the conclusions of this review. Further studies are needed to identify the risk/benefit ratio of different delivery techniques and dosing schedules for the administration of these medications. Studies need to address both the short‐ and long‐term benefits and adverse effects of inhaled steroids with particular attention to neurodevelopmental outcome". </p> <p>It is noteworthy that a Cochrane Review by <a href="./references#CD002057-bbs2-0040" title="OnlandW , DeJaegereAPMC , OffringaM , vanKaamA . Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010941.pub2] ">Onland 2017b</a> concluded: "Despite the fact that some studies reported a modulating effect of treatment regimens in favour of higher‐dosage regimens on the incidence of BPD and neurodevelopmental impairment, recommendations on the optimal type of corticosteroid, the optimal dosage, or the optimal timing of initiation for the prevention of BPD in preterm infants cannot be made based on current level of evidence. A well‐designed large RCT is urgently needed to establish the optimal systemic postnatal corticosteroid dosage regimen". </p> <p>Apart from studies included in this review, we are not aware of any other direct comparisons of early use of inhaled versus systemic corticosteroids. </p> </section> <section id="CD002057-sec-0033"> <h3 class="title" id="CD002057-sec-0033">How the intervention might work</h3> <p>It is thought that inflammation in the lungs may be part of the cause of BPD (<a href="./references#CD002057-bbs2-0034" title="NelinLD , LoganJW . The use of inhaled corticosteroids in chronically ventilated preterm infants. Seminars in Fetal &amp; Neonatal Medicine2017;22(5):296‐301. [DOI: 10.1016/j.siny.2017.07.005; PUBMED: 28768578] ">Nelin 2017</a>). As part of a randomised, placebo‐controlled trial of early inhaled beclomethasone therapy, <a href="./references#CD002057-bbs2-0021" title="GuptaGK , ColeCH , AbbasiS , DemissieS , NijnimbamC , NielsenHC . Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL8 and IL‐Ira in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatric Pulmonology2000;30(4):275‐81. ">Gupta 2000</a> measured interleukin‐8 (IL‐8) and interleukin‐1 receptor antagonist (IL‐1ra) concentrations in tracheal aspirates as markers of pulmonary inflammation. Beclomethasone‐treated infants with moderately elevated baseline IL‐8 levels received less subsequent systemic glucocorticoid therapy and had a lower incidence of BPD than non treated infants. <a href="./references#CD002057-bbs2-0021" title="GuptaGK , ColeCH , AbbasiS , DemissieS , NijnimbamC , NielsenHC . Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL8 and IL‐Ira in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatric Pulmonology2000;30(4):275‐81. ">Gupta 2000</a> and co‐authors concluded that early‐inhaled beclomethasone therapy was associated with a reduction in pulmonary inflammation after one week of therapy. Corticosteroid drugs when given orally or intravenously reduces this inflammation in the lungs (<a href="./references#CD002057-bbs2-0034" title="NelinLD , LoganJW . The use of inhaled corticosteroids in chronically ventilated preterm infants. Seminars in Fetal &amp; Neonatal Medicine2017;22(5):296‐301. [DOI: 10.1016/j.siny.2017.07.005; PUBMED: 28768578] ">Nelin 2017</a>). Corticosteroid use has been associated with cerebral palsy and developmental delay (<a href="./references#CD002057-bbs2-0006" title="American Academy ofPediatrics , Committee on Fetus and Newborn, Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics2002;109(2):330–8. ">AAP &amp; CPS 2002</a>; <a href="./references#CD002057-bbs2-0034" title="NelinLD , LoganJW . The use of inhaled corticosteroids in chronically ventilated preterm infants. Seminars in Fetal &amp; Neonatal Medicine2017;22(5):296‐301. [DOI: 10.1016/j.siny.2017.07.005; PUBMED: 28768578] ">Nelin 2017</a>). In a retrospective study of infants born at &lt; 29 weeks PMA and assessed at 18 to 21 months corrected age it was found that exposure to inhaled steroids was not associated with increased odds of death or neurodevelopmental impairment (<a href="./references#CD002057-bbs2-0031" title="KellyEN , ShahVS , LevenbachJ , VincerM , DaSilvaO , ShahPS , Canadian Neonatal Network and Canadian Neonatal Follow‐Up Network Investigators. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates. Journal of Maternal‐fetal &amp; Neonatal Medicine 2017 July 16 [Epub ahead of print]. [DOI: 10.1080/14767058.2017.1350644; PUBMED: 28714339] ">Kelly 2017</a>). However, in the same study systemic steroids use before 4 weeks of age was associated with significantly worse outcomes (<a href="./references#CD002057-bbs2-0031" title="KellyEN , ShahVS , LevenbachJ , VincerM , DaSilvaO , ShahPS , Canadian Neonatal Network and Canadian Neonatal Follow‐Up Network Investigators. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates. Journal of Maternal‐fetal &amp; Neonatal Medicine 2017 July 16 [Epub ahead of print]. [DOI: 10.1080/14767058.2017.1350644; PUBMED: 28714339] ">Kelly 2017</a>). It is important to minimize exposure to the potentially harmful effects of corticosteroids, particularly on the developing brain (<a href="./references#CD002057-bbs2-0018" title="DoyleLW , CheongJLY . Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Who might benefit?. Seminars in Fetal &amp; Neonatal Medicine2017;22(5):290‐5. [DOI: 10.1016/j.siny.2017.07.003; PUBMED: 28734731] ">Doyle 2017</a>). </p> </section> <section id="CD002057-sec-0034"> <h3 class="title" id="CD002057-sec-0034">Why it is important to do this review</h3> <p>Cochrane Reviews have addressed the use of systemic or inhaled corticosteroids in the prevention or treatment of BPD or chronic lung disease. These include reviews of the early use (&lt; 8 days) of systemic postnatal corticosteroids to prevent chronic lung disease (<a href="./references#CD002057-bbs2-0016" title="DoyleLW , HallidayHL , EhrenkranzRA . Early (&lt; 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001146.pub4] ">Doyle 2014</a>) and the late use (&gt; 7 days) of systemic postnatal corticosteroids for chronic lung disease (<a href="./references#CD002057-bbs2-0017" title="DoyleLW , HallidayHL , EhrencranzRA . Late (&gt; 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001145.pub3] ">Doyle 2014a</a>). </p> <p>Other Cochrane Reviews address the use of inhaled corticosteroids in the prevention or treatment of chronic lung disease. <a href="./references#CD002057-bbs2-0048" title="ShahVS , OhlssonA , HallidayHL , DunnM . Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD001969.pub4] ">Shah 2017</a> reviewed the effects of early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates and <a href="./references#CD002057-bbs2-0039" title="OnlandW , OffringaM , vanKaamA . Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 8. [DOI: 10.1002/14651858.CD002311.pub4] ">Onland 2017a</a> reviewed the late use (≥ 7 days) of inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. </p> <p>Cochrane Reviews have also compared systemic and inhaled corticosteroids. <a href="./references#CD002057-bbs2-0047" title="ShahSS , OhlssonA , HallidayH , ShahVS . Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD002058.pub2] ">Shah 2012</a> compared the use of inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates, and the use of inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants (<a href="./references#CD002057-bbs2-0060" title="ShahSS , OhlssonA , HallidayHL , ShahVS . Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD002057.pub3] ">Shah 2012a</a>). </p> <p>The use of corticosteroids for other indications in neonates including intravenous dexamethasone to facilitate extubation (<a href="./references#CD002057-bbs2-0015" title="DavisPG , Henderson‐SmartDJ . Intravenous dexamethasone for extubation of newborn infants. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD000308] ">Davis 2001</a>), corticosteroids for the treatment of hypotension (<a href="./references#CD002057-bbs2-0026" title="IbrahimH , SinhaIP , SubhedarNV . Corticosteroids for treating hypotension in preterm infants. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD003662.pub4] ">Ibrahim 2011</a>) and corticosteroids for the treatment of meconium aspiration syndrome (<a href="./references#CD002057-bbs2-0054" title="WardMC , SinnJKH . Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD003485] ">Ward 2003</a>) have been assessed in Cochrane Reviews. </p> <p>In statements released by the European Association of Perinatal Medicine (<a href="./references#CD002057-bbs2-0023" title="HallidayHL . Guidelines on neonatal steroids. Prenatal and Neonatal Medicine2001;6(6):371‐3. ">Halliday 2001a</a>), American Academy of Pediatrics (<a href="./references#CD002057-bbs2-0055" title="WatterbergKL , American Academy of Pediatrics. Committee of Fetus and Newborn. Policy statement ‐ postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics2010;126(4):800‐8. ">Watterberg 2010</a>) and the Canadian Pediatric Society (<a href="./references#CD002057-bbs2-0028" title="JefferiesAL . Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Journal of Paediatrics and Child Health2012;17(10):573‐4. ">Jefferies 2012</a>), routine use of systemic dexamethasone for the prevention or treatment of BPD is not recommended. These recommendations were based on concerns regarding short and long‐term complications, especially cerebral palsy. </p> <p>Thus, alternatives to systemic corticosteroids that may have fewer adverse consequences need to be investigated. Administration of corticosteroids topically through the respiratory tract might result in beneficial effects on the pulmonary system with fewer undesirable systemic side effects. </p> <p>The aim of this review was to examine the effectiveness of inhaled versus systemic corticosteroids administered to ventilator‐dependent very low birth weight neonates of 1500 g or less after the first week of life, for the treatment of evolving BPD. This is an update of our review last published in 2012 (<a href="./references#CD002057-bbs2-0060" title="ShahSS , OhlssonA , HallidayHL , ShahVS . Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD002057.pub3] ">Shah 2012a</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002057-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-sec-0149">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002057-sec-0035"></div> <p>The primary objective was to compare the effectiveness of inhaled versus systemic corticosteroids administered to ventilator‐dependent preterm neonates with birth weight ≤ 1500 g or gestational age ≤ 32 weeks after 7 days of life on the incidence of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age. </p> <section id="CD002057-sec-0036"> <h3 class="title" id="CD002057-sec-0036">Secondary objectives</h3> <p>To compare the effectiveness of inhaled versus systemic corticosteroids on other indicators of BPD, the incidence of adverse events, and long‐term neurodevelopmental outcome. </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002057-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-sec-0151">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002057-sec-0037"></div> <section id="CD002057-sec-0038"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002057-sec-0039"> <h4 class="title">Types of studies</h4> <p>Randomised or quasi‐randomised clinical trials.</p> </section> <section id="CD002057-sec-0040"> <h4 class="title">Types of participants</h4> <p>Ventilator‐dependent preterm infants with birth weight ≤ 1500 g or gestational age ≤ 32 weeks and postnatal age of more than 7 days of age. </p> </section> <section id="CD002057-sec-0041"> <h4 class="title">Types of interventions</h4> <p>Inhaled corticosteroids compared to systemic corticosteroids irrespective of the type, dose and duration of therapy as long as the treatment started before 7 days of age. </p> </section> <section id="CD002057-sec-0042"> <h4 class="title">Types of outcome measures</h4> <p>For the following two comparisons:</p> <p><b>1. Inhaled versus systemic steroids among infants ‐ outcomes including deaths (infants randomised at &lt; 72 hours of age)</b> </p> <p><b>2. Inhaled versus systemic steroids among infants ‐ outcomes including deaths (infants randomised between 12 and 21 days of age)</b> </p> <section id="CD002057-sec-0043"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD002057-list-0001"> <li> <p>Death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age.</p> </li> </ul> </p> </section> <section id="CD002057-sec-0044"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD002057-list-0002"> <li> <p>Death or BPD at 28 days of age</p> </li> <li> <p>Death at 36 week's postmenstrual age</p> </li> <li> <p>Death at 28 days of age</p> </li> </ul> </p> <p>For the following comparison:</p> <section id="CD002057-sec-0045"> <h6 class="title">3. Inhaled versus systemic steroids among infants ‐ (infants randomised at &lt; 72 hours of age or between 12 and 21 days of age) </h6> </section> <section id="CD002057-sec-0046"> <h6 class="title">Secondary outcomes</h6> <p> <ul id="CD002057-list-0003"> <li> <p>BPD at 36 weeks' postmenstrual age (requirement for supplemental oxygen at 36 weeks' postmenstrual age) </p> </li> <li> <p>BPD at 28 days of age (requirement for supplemental oxygen at 28 days of age)</p> </li> <li> <p>Need for ventilation amongst survivors at 36 weeks' postmenstrual age</p> </li> <li> <p>Duration of mechanical ventilation among survivors (days)</p> </li> <li> <p>Duration of supplemental oxygen among survivors (days)</p> </li> <li> <p>Length of hospital stay among survivors (days)</p> </li> <li> <p>Intraventricular haemorrhage grade III‐IV (defined as per <a href="./references#CD002057-bbs2-0041" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 grams. Journal of Pediatrics1978;92(4):529‐34. ">Papile 1978</a>) </p> </li> <li> <p>Periventricular leukomalacia (defined as cysts in the periventricular area on ultrasound or CT scan) </p> </li> <li> <p>Hyperglycaemia (defined as blood glucose &gt; 10 mmol/L) during the course of intervention</p> </li> <li> <p>Hypertension (defined as systolic or diastolic blood pressure &gt; 2 standard deviations (SD) above the mean for infant's gestational and postnatal age (<a href="./references#CD002057-bbs2-0058" title="ZubrowA , HulmanS , KushnerH , FalknerB . Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. Journal of Perinatology1995;15(6):470‐9. ">Zubrow 1995</a>)) during the course of intervention </p> </li> <li> <p>Necrotising enterocolitis (Bell's stage II and III) (<a href="./references#CD002057-bbs2-0011" title="BellMJ , TernbergJL , FeiginRD , KeatingJP , MarshallR , BartonL , et al. Neonatal necrotising enterocolitis: Therapeutic decisions based upon clinical staging. Annals of Surgery1978;187(1):1‐7. ">Bell 1978</a>) </p> </li> <li> <p>Gastrointestinal bleed (defined as presence of bloody nasogastric or orogastric aspirate)</p> </li> <li> <p>Retinopathy of prematurity ≥ stage 3 (<a href="./references#CD002057-bbs2-0027" title="The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Archives of Ophthalmology1984;102:1130‐4. ">ICROP 1984</a>) </p> </li> <li> <p>Culture‐proven sepsis</p> </li> <li> <p>Suppression of the hypothalamic‐pituitary‐adrenal axis assessed by metyrapone or Adrenocorticotropic hormone (ACTH) stimulation test </p> </li> <li> <p>Patent ductus arteriosus defined by presence of clinical symptoms and signs or demonstration by echocardiography </p> </li> <li> <p>Hypertrophic cardiomyopathy defined as thickening of the intraventricular septum or of the left ventricular wall on echocardiography; sepsis defined by the presence of clinical symptoms and signs of infection and a positive culture from a normally sterile site </p> </li> <li> <p>Pneumonia based on clinical and radiological signs and a positive endotracheal tube aspirate culture </p> </li> <li> <p>Growth (weight, length/height and head circumference) at 36 weeks' postmenstrual age; cataracts (defined by presence of opacities in the lens) </p> </li> <li> <p>Hypertrophy of the tongue</p> </li> <li> <p>Nephrocalcinosis (defined by the presence of echo densities in the medulla of the kidney on ultrasound) (<a href="./references#CD002057-bbs2-0044" title="SaarelaT , VaaralaA , LanningP , KoivistoM . Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birth‐weight infants. Acta Paediatrica1999;86(6):655‐60. ">Saarela 1999</a>) </p> </li> </ul> </p> <p><b>Long‐term neurodevelopmental outcome (in surviving infants)</b> </p> <p> <ul id="CD002057-list-0004"> <li> <p>Neurodevelopmental impairment was defined as presence of cerebral palsy or mental impairment (Bayley scales of infant development, Mental Developmental Index &lt; 70) or legal blindness (&lt; 20/200 visual acuity) or deafness (aided or &lt; 60 dB on audiometric testing) assessed at 18 to 24 months. </p> </li> </ul> </p> <p><b>The following outcomes were reported at 7 years of age: these post‐hoc analyses were based on available data from a subsample of the</b><a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> study </p> <p> <ul id="CD002057-list-0005"> <li> <p>British Ability Scales, Second Edition (provides a global measure of cognitive functioning (the general conceptual ability (GCA) score, with a standardised mean of 100 and SD of 15) </p> </li> <li> <p>Activities, social, and school competency scales of the Child Behaviour Checklist (CBCL) for children 4 to 18 years of age </p> </li> <li> <p>Strengths and Difficulties Questionnaire (SDQ) from which overall behavioural, emotional, conduct, hyperactivity, and peer problem scores are derived </p> </li> <li> <p>Cerebral palsy</p> </li> <li> <p>Severe disability defined as GCA score of &lt; 55, no independent walking, inability to dress or feed oneself, requirement for continuous home oxygen therapy, behavioural disturbance requiring constant supervision, no useful vision, or no useful hearing </p> </li> <li> <p>Moderate disability was defined as a GCA score of 55 to 69, restricted mobility, admission to an ICU and ventilation within the past year, secondary referral for specialised help with behaviour, ability to see gross movement only or hearing loss not corrected with aid </p> </li> <li> <p>Death or moderate/severe disability</p> </li> <li> <p>Systolic blood pressure &gt; 95th percentile</p> </li> <li> <p>Diastolic blood pressure &gt; 95th percentile</p> </li> <li> <p>Ever diagnosed as asthmatic by 7 years of age</p> </li> <li> <p>Severe disability defined as GCA score of &lt; 55, no independent walking, inability to dress or feed oneself, requirement for continuous home oxygen therapy, behavioural disturbance requiring constant supervision, no useful vision, or no useful hearing </p> </li> <li> <p>Moderate disability was defined as a GCA score of 55 to 69, restricted mobility, admission to an ICU and ventilation within the past year, secondary referral for specialised help with behaviour, ability to see gross movement only or hearing loss not corrected with aid </p> </li> <li> <p>Death or moderate/severe disability</p> </li> <li> <p>Systolic blood pressure &gt; 95th percentile</p> </li> <li> <p>Diastolic blood pressure &gt; 95th percentile</p> </li> <li> <p>Ever diagnosed as asthmatic by 7 years of age</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD002057-sec-0047"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD002057-sec-0048"> <h4 class="title">Electronic searches</h4> <p>We used the criteria and standard methods of Cochrane and Cochrane Neonatal for the 2017 update (see <a href="http://neonatal.cochrane.org/resources-review-authors" target="_blank">the Cochrane Neonatal search strategy for specialized register</a>). </p> <p>We conducted a comprehensive search including: Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 1) in The Cochrane Library; MEDLINE via PubMed (1 January 2011 to 23 February 2017); Embase (1 January 2011 to 23 February 2017); and CINAHL (1 January 2011 to 23 February 2017) using the following search terms: (bronchopulmonary dysplasia OR lung diseases OR chronic lung disease OR BPD OR CLD) AND ((anti‐inflammatory agents OR steroid* OR dexamethasone OR budesonide OR beclomethasone dipropionate OR flunisolide OR fluticasone propionate OR corticosteroid* OR betamethasone OR hydrocortisone) AND (inhalation OR aerosol OR inhale*)), plus database‐specific limiters for RCTs and neonates. See <a href="./appendices#CD002057-sec-0130">Appendix 1</a> for previous search methodologies and <a href="./appendices#CD002057-sec-0131">Appendix 2</a> for the full search strategies for each database searched for the 2017 update. </p> <p>We searched clinical trials registries for ongoing or recently completed trials (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>; the World Health Organization International Trials Registry Platform (<a href="http://www.whoint/ictrp/search/en/" target="_blank">WHO ICTRP</a>); and the <a href="https://www.isrctn.com/" target="_blank">ISRCTN Registry</a>). We searched <a href="http://www.abstracts2view.com/pas/" target="_blank">Abstracts2View</a> for abstracts from the Pediatric Academic Societies Annual Meetings from 2010 to 2016. </p> </section> <section id="CD002057-sec-0049"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of identified trials.</p> </section> </section> <section id="CD002057-sec-0050"> <h3 class="title" id="CD002057-sec-0050">Data collection and analysis</h3> <p>We used the methods of the Cochrane Neonatal Review Group for data collection and analysis. </p> <section id="CD002057-sec-0051"> <h4 class="title">Selection of studies</h4> <p>Three review authors (SS, AO, VS) independently screened titles and abstracts for inclusion of all potential studies identified as a result of the search. </p> <p>We retrieved full‐text study reports and three review authors (SS, AO, VS) independently screened the reports and identified studies for inclusion, and noted and recorded reasons for exclusion of ineligible studies. We resolved disagreement through discussion or, if required, we consulted a fourth review author (HH). We identified and excluded duplicates and collated multiple reports of the same study so that each study rather than each report was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (<a href="#CD002057-fig-0001">Figure 1</a>) and <a href="./references#CD002057-sec-0143" title="">Characteristics of excluded studies</a>. We did not impose any language restrictions </p> <div class="figure" id="CD002057-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram: review update" data-id="CD002057-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> </div> </section> <section id="CD002057-sec-0052"> <h4 class="title">Data extraction and management</h4> <p>For each trial, information was sought regarding the method of randomisation, blinding and reporting of outcomes of all infants enrolled in the trial. Data from primary investigators were obtained for unpublished trials or when published data were incomplete. Retrieved articles were assessed and data extracted independently by four review authors (SS, VS, AO, HH). This update was performed by two review authors (VS, AO). Discrepancies were resolved by discussion and consensus. </p> <p>For each study, data were entered into RevMan by one review author and checked for accuracy by a second reviewer author. We resolved discrepancies through discussion.  </p> <p>We attempted to contact authors of original reports to provide further details when information in published reports was unclear. </p> </section> <section id="CD002057-sec-0053"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three review authors (VS, SS, AO) independently assessed the risk of bias (low, high, or unclear) of all included trials using the Cochrane ‘Risk of bias’ tool (<a href="./references#CD002057-bbs2-0025" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Cochrane Collaboration. ">Higgins 2011</a>) for the following domains: </p> <p> <ul id="CD002057-list-0006"> <li> <p>Sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessment (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias).</p> </li> <li> <p>Other bias.</p> </li> </ul> </p> <p>Disagreements were resolved by discussion or by consulting a third review author. See <a href="./appendices#CD002057-sec-0132">Appendix 3</a> for a more detailed description of risk of bias for each domain.  </p> </section> <section id="CD002057-sec-0054"> <h4 class="title">Measures of treatment effect</h4> <p>We performed statistical analyses using Review Manager software (<a href="./references#CD002057-bbs2-0042" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). Dichotomous data were analysed using relative risk (RR), risk difference (RD) and the number needed to benefit (NNTB) or number needed to harm (NNTH). The 95% confidence interval (CI) was reported for all estimates. </p> <p>We analysed continuous data using weighted mean difference (WMD) or the standardised mean difference (SMD) to combine trials that measured the same outcome but used different methods. </p> </section> <section id="CD002057-sec-0055"> <h4 class="title">Unit of analysis issues</h4> <p>For clinical outcomes, such as episodes of sepsis, we analysed data as the proportion of neonates having one or more episodes. </p> </section> <section id="CD002057-sec-0056"> <h4 class="title">Dealing with missing data</h4> <p>Levels of attrition were noted for the included studies. The impact of including studies with high levels of missing data in the overall assessment of treatment effect was explored by conducting sensitivity analyses. </p> <p>All outcome analyses were on an intention‐to‐treat basis i.e. we included all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD002057-sec-0057"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity among trials by inspecting the forest plots and quantifying the impact of heterogeneity using the I² statistic. If noted, we planned to explore the possible causes of statistical heterogeneity using prespecified subgroup analysis (e.g. differences in study quality, participants, intervention regimens, or outcome assessments). Heterogeneity tests, including the I² statistic, were performed to assess the appropriateness of pooling data. We used the following criteria to describe heterogeneity: &lt; 25% no heterogeneity, ≥ 25% to 49% low heterogeneity, ≥ 50% to 74% moderate heterogeneity and ≥ 75% high heterogeneity. </p> </section> <section id="CD002057-sec-0058"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess possible publication bias and other biases by inspecting the symmetry or asymmetry of funnel plots had there been at least 10 trials included in an analysis. </p> <p>For included trials that were recently performed (and therefore prospectively registered), we explored possible selective reporting of study outcomes by comparing the primary and secondary outcomes in the reports with the primary and secondary outcomes proposed at trial registration, using the web sites www.clinicaltrials.gov and www.controlled‐trials.com. If such discrepancies were found, we planned to contact the primary investigators to obtain missing outcome data on outcomes pre‐specified at trial registration. </p> </section> <section id="CD002057-sec-0059"> <h4 class="title">Data synthesis</h4> <p>Meta‐analysis was conducted using Review Manager software (<a href="./references#CD002057-bbs2-0042" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used the Mantel‐Haenszel method for estimates of typical relative risk and risk difference. We analysed continuous measures using the inverse variance method. We used the fixed‐effect model for all meta‐analyses. </p> <section id="CD002057-sec-0060"> <h5 class="title">Quality of evidence</h5> <p>We used the GRADE approach, as outlined in the GRADE Handbook (<a href="./references#CD002057-bbs2-0045" title="SchünemannH , BrożekJ , GuyattG , OxmanA (eds) , GRADE Working Group. GRADE Handbook 2013. gdt.gradepro.org/app/handbook/handbook.html (accessed prior to 8 September 2017). ">Schünemann 2013</a>), to assess the quality of evidence for the following (clinically relevant) primary outcomes: death or BPD at 36 weeks' postmenstrual age for infants randomised at &lt; 72 hours of age and for infants randomised between 12 and 21 days of age. For secondary outcomes we included infants randomised at &lt; 72 hours or between 12 and 21 days; BPD at 36 weeks' postmenstrual age; hyperglycaemia; hypertension. For infants randomised at &lt; 72 hours of age we included the following outcomes at 7 years of age: general conceptual ability (GCA); moderate/severe disability; death or moderate/severe disability; systolic blood pressure &gt; 95th percentile; diastolic blood pressure &gt; 95th percentile; and ever diagnosed as asthmatic. </p> <p>Three authors (VS, SS, AO) independently assessed the quality of the evidence for each of these outcomes. We considered evidence from randomised controlled trials as high quality but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias. We used <a href="./references#CD002057-bbs2-0019" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 23 February 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a> to create ‘Summary of findings’ tables to report the quality of the evidence. </p> <p>The GRADE approach results in an assessment of the quality of a body of evidence in one of four grades: </p> <p> <ol id="CD002057-list-0007"> <li> <p>High: We are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ol> </p> </section> </section> <section id="CD002057-sec-0061"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Groups were analysed based on all randomised and survivors only.</p> </section> <section id="CD002057-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses for situations where this might affect the interpretation of significant results (e.g. where there is risk of bias associated with the quality of some of the included trials or missing outcome data). However, it was determined this was unnecessary for this review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002057-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002057-sec-0063"></div> <section id="CD002057-sec-0064"> <h3 class="title">Description of studies</h3> <p>Three trials were identified and included in the previous review. The updated searches of databases and trials registers in 2017 identified a total of 427 records. After removal of duplicates, we assessed 395 records by title and abstract and excluded all 395 records. The study flow from the searches is illustrated in <a href="#CD002057-fig-0001">Figure 1</a>. One study received grant support and the industry provided Aerochambers and metered dose inhalers of budesonide and placebo for the same study. No conflict of interest was identified. </p> <section id="CD002057-sec-0065"> <h4 class="title">Results of the search</h4> <p>Five trials comparing inhaled versus systemic corticosteroids in treatment of BPD were identified. Two trials (<a href="./references#CD002057-bbs2-0004" title="DimitriouG , GreenhoughA , GiffinFJ , KavadiaV . Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. European Journal of Pediatrics1997;156(1):51‐5. ">Dimitriou 1997</a>; <a href="./references#CD002057-bbs2-0005" title="NichollRM , GreenoughA , KingM , CheesemanP , GamsuHR . Growth effects of systemic versus inhaled steroids in chronic lung disease. Archives of Disease in Childhood2002;87(1):F59‐61. ">Nicholl 2002</a>) were excluded as both included non ventilator‐dependent patients and the groups of ventilated infants could not be identified separately. No new studies were included for this update. </p> </section> <section id="CD002057-sec-0066"> <h4 class="title">Included studies</h4> <p>Three trials fulfilled the inclusion criteria and were included in the previous update of the review (<a href="./references#CD002057-bbs2-0060" title="ShahSS , OhlssonA , HallidayHL , ShahVS . Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD002057.pub3] ">Shah 2012a</a>): <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>; <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> and <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a>. Although <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> enrolled preterm infants with birth weights between 650 g and 2000 g, on review of the published data, 93% of the enrolled infants had birth weights &lt; 1000 g with postmenstrual age ranging from 23 to 31 weeks. Therefore, data from this trial were included in this review. Details of each trial are given in <a href="./references#CD002057-sec-0142" title="">Characteristics of included studies</a>. </p> <p><a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> enrolled infants born at &lt; 30 weeks gestation, postnatal age &lt; 72 hours, needing mechanical ventilation and fractional inspired oxygen concentration (FiO₂) &gt; 0.30. Infants of 30 and 31 weeks gestation could also be included if they needed FiO₂ &gt; 0.50. Infants with lethal congenital anomalies, severe intraventricular haemorrhage (grade 3 or 4), or proven systemic infection before entry were excluded from the trial. The trial was designed to evaluate the effectiveness of early (&lt; 72 hours) or delayed (&gt; 15 days) administration of systemic dexamethasone or inhaled budesonide. Infants were randomly allocated to one of four treatment groups in a factorial design: early (&lt; 72 hours) dexamethasone, early budesonide, delayed selective (&gt; 15 days) dexamethasone and delayed selective budesonide. Only the delayed budesonide and delayed dexamethasone groups are included in this review. <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> randomised 142 babies to delayed selective budesonide and 150 to delayed selective dexamethasone groups. Budesonide was administered by metered dose inhaler and a spacing chamber at 400 µg/kg twice daily for 12 days. Dexamethasone was given intravenously (IV) or orally in a tapering course beginning with 0.5 mg/kg/day in two divided doses for three days reducing by half every three days for a total of 12 days of therapy. Delayed selective treatment was started if infants needed mechanical ventilation and more than 30% oxygen for &gt; 15 days. Of 142 infants randomised to the delayed selective budesonide group, 33 received a full course, 21 received a partial course and 88 babies did not receive budesonide. Of 150 infants randomised to the delayed selective dexamethasone group, 35 received a complete course, 25 received a partial course and 90 infants did not receive dexamethasone. An intention‐to‐treat analysis was performed. The primary outcome was death or oxygen dependency at 36 weeks. Secondary outcome measures included death or major cerebral abnormality, duration of oxygen treatment, and complications of preterm birth. Long‐term outcomes at 7 years of age were assessed in a sample from the UK and Ireland by assessors blinded to the treatment assignments. </p> <p><a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> compared inhaled beclomethasone, either 400 or 800 µg/d, to intravenous dexamethasone in preterm infants dependent on conventional mechanical ventilation and supplemental oxygen at two weeks of age. The study included 78 preterm infants with birth weight ≤ 1500 g, gestational age ≤ 30 weeks and ventilatory dependence at 12 to 21 days of age with rate &gt; 15/min and FiO₂ &gt; 0.30 with a persistence of these ventilator settings for a minimum of 72 hours. Infants on high frequency ventilation were ineligible for inclusion in the study. Infants were excluded from the study if they had major congenital malformations, culture‐proven sepsis, hypertension or hyperglycaemia needing treatment, or persistent patent ductus arteriosus. Infants were randomly assigned to one of the three treatment groups: inhaled beclomethasone at 400 µg/d or 800 µg/d, or intravenous dexamethasone. Inhaled beclomethasone was continued until extubation. Post‐extubation the same dose was continued for another 48 hours. After that, the dose was halved every other day for six days, after which the steroids were stopped. Based on our inclusion criteria (to include all studies regardless of dosage of inhaled steroids), and because there was no significant difference in the effects of the two different doses, the two inhaled beclomethasone groups in <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> were combined to form one group in the present review. Intravenous dexamethasone was given as a 42 day tapering course starting with 0.5 mg/kg/day in two divided doses (<a href="./references#CD002057-bbs2-0008" title="AveryGB , FletcherAB , KaplanM , BrudnoDS . Controlled trial of dexamethasone in respirator‐dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75(1):106‐11. ">Avery 1985</a>). Cross‐over from either of the inhaled beclomethasone groups to intravenous dexamethasone was allowed if after four to five days of inhaled beclomethasone, the infant's ventilator and oxygen support had not decreased and the attending neonatologist felt that the infant could benefit from intravenous dexamethasone. It was reported that 18 infants from the inhaled steroid group crossed over to systemic dexamethasone. An intention‐to‐treat analysis was performed by the investigators. Outcome measures included adverse effects including sepsis, hypertension and hyperglycaemia; short‐term ventilatory requirements, duration of mechanical ventilation, duration of supplemental oxygen, length of stay in the hospital and need for respiratory support at 28 days or 36 weeks' postmenstrual age. Deaths at 36 weeks' postmenstrual age were not reported. For infants completing a 10 day course of either inhaled or intravenous steroids, an adrenocorticotropic hormone (ACTH) stimulation test was done two weeks after completion of the steroid course. </p> <p><a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> enrolled 61 preterm infants with birth weights between 650 g and 2000 g who at 14 days of age were at significant risk of developing moderate to severe BPD (defined as the need for mechanical ventilation and oxygen) with x‐ray changes beyond 28 days of life. Infants with culture‐proven sepsis and who were receiving FiO₂ of ≥ 0.30 were eligible if they had a ventilatory index (10,000/ventilator rate x peak pressure x pCO₂) of &lt; 0.8. Infants without previous sepsis were eligible if the ventilatory index was &lt; 0.51. Infants meeting these criteria had a 75% risk of developing moderate‐severe BPD. Infants with the following were excluded: pre‐existing hyperglycaemia with blood glucose &gt; 200 mg/dL for &gt; 24 hours, hypertension with systolic pressures &gt; 70 to 90 mm Hg, depending on birth weight, surgery within previous seven days, active bacterial infection unless repeat blood, urine or cerebrospinal fluid cultures were sterile after 72 hours of antibiotics, thrombocytopenia with platelet count &lt; 100,000, any gastrointestinal bleeding within the previous seven days, significant weaning from ventilator support in the previous three days and previous exposure to postnatal steroids. Eligibility was determined at 14 days of age but the study could be delayed up to six days while awaiting resolution of infections. Infants were randomised to the following four groups: Group A: aerosol placebo‐systemic dexamethasone; Group B: high beclomethasone‐systemic placebo; Group C: medium beclomethasone‐systemic placebo; and Group D: low beclomethasone‐systemic placebo. Those receiving aerosol steroids who remained ventilator‐dependent after seven days were switched to standard 42‐day tapering doses of systemic dexamethasone. The primary outcome variable was extubation within the first seven days of the study. Secondary outcome measures included: changes in ventilatory settings and oxygen delivery over the first seven days, the incidence of hypertension, hyperglycaemia, infection and growth. </p> </section> <section id="CD002057-sec-0067"> <h4 class="title">Excluded studies</h4> <p>We excluded two trials (<a href="./references#CD002057-bbs2-0004" title="DimitriouG , GreenhoughA , GiffinFJ , KavadiaV . Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. European Journal of Pediatrics1997;156(1):51‐5. ">Dimitriou 1997</a>; <a href="./references#CD002057-bbs2-0005" title="NichollRM , GreenoughA , KingM , CheesemanP , GamsuHR . Growth effects of systemic versus inhaled steroids in chronic lung disease. Archives of Disease in Childhood2002;87(1):F59‐61. ">Nicholl 2002</a>). Both trials included non ventilator‐dependent participants and the groups of ventilated infants could not be identified separately. See <a href="./references#CD002057-sec-0143" title="">Characteristics of excluded studies</a>. </p> <section id="CD002057-sec-0068"> <h5 class="title">Studies awaiting classification</h5> <p>There are no studies awaiting classification.</p> </section> <section id="CD002057-sec-0069"> <h5 class="title">Ongoing studies</h5> <p>Our searches did not find any ongoing studies.</p> </section> </section> </section> <section id="CD002057-sec-0070"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias in the included trials are illustrated in <a href="#CD002057-fig-0002">Figure 2</a> and <a href="#CD002057-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD002057-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD002057-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD002057-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD002057-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>The risk of bias is taken into account in the 'Summary of findings' tables for the primary outcome and important secondary outcomes (<a href="./full#CD002057-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD002057-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD002057-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD002057-tbl-0004">summary of findings Table 4</a>). Reasons for downgrading the quality of evidence is explained in the comments columns in 'Summary of findings' tables. </p> <p>There were elements of risk of bias in the three included studies. For details see the information below. </p> <section id="CD002057-sec-0071"> <h4 class="title">Allocation</h4> <p>In the study by <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> after identifying an eligible infant, the clinician telephoned the randomisation centre to enrol the infant and to determine the treatment group (low risk of bias). </p> <p><a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> was a prospective randomised controlled trial. Three sets of 27 cards were assembled followed by placement of one card each into one of 81 opaque envelopes. As infants were enrolled, a card was sequentially pulled and the infant assigned to the appropriate study group (low risk of bias). </p> <p><a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> was a prospective randomised double‐blind controlled trial. The infants were randomised using a random table number and only the pharmacy was aware of the individual group assignment (low risk of bias). </p> </section> <section id="CD002057-sec-0072"> <h4 class="title">Blinding</h4> <p><a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> was a multi‐centre RCT involving 47 centres. The interventions and outcome measures were not blinded in all the centres (high risk of bias). However, in 11 centres the trial was conducted double blind. In these centres, placebo metered dose inhalers and intravenous saline were used to mask treatment allocation. Comparisons were made for the primary outcome variables between the centres observing double blind strategy and the other centres. The long‐term assessments at 7 years of age were performed by assessors blinded to the group assignments (low risk of bias). </p> <p>In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> blinding of the intervention was not performed (high risk of bias). Blinding of outcome measurement was not ensured (high risk of bias). Cross‐over from inhaled steroid groups to intravenous dexamethasone was allowed at the discretion of attending neonatologist. </p> <p>In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> blinding of intervention was performed (low risk of bias). Blinding of outcome measurement was unclear (unclear risk of bias). </p> </section> <section id="CD002057-sec-0073"> <h4 class="title">Incomplete outcome data</h4> <p>There was complete follow up of all randomised infants in all three studies (low risk of bias in all three studies). </p> </section> <section id="CD002057-sec-0074"> <h4 class="title">Selective reporting</h4> <p>There was no selective reporting in the trial by <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> (low risk of bias ). The protocols for the other trials were not available, so we can not judge if there were any deviations or not. </p> </section> <section id="CD002057-sec-0075"> <h4 class="title">Other potential sources of bias</h4> <p>We are not aware of any other sources of bias in the included trials (unclear risk).</p> </section> </section> <section id="CD002057-sec-0076"> <h3 class="title" id="CD002057-sec-0076">Effects of interventions</h3> <p>See: <a href="./full#CD002057-tbl-0001"><b>Summary of findings for the main comparison</b> Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours of age)</a>; <a href="./full#CD002057-tbl-0002"><b>Summary of findings 2</b> Inhaled steroids compared with systemic steroids for BPD (infants randomised between 12 and 21 days of age)</a>; <a href="./full#CD002057-tbl-0003"><b>Summary of findings 3</b> Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</a>; <a href="./full#CD002057-tbl-0004"><b>Summary of findings 4</b> Inhaled steroids compared with systemic steroids for BPD ‐ long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours of age)</a> </p> <p><a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> randomised infants at &lt; 72 hours of age; <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> randomised infants at 12 to 21 days; and <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> randomised after 14 days of age. All trials reported outcomes from the age of randomisation. Although infants received steroids after the first two weeks of life in all trials, the time period over which outcomes were measured differed among studies. Data from all three trials were combined for meta‐analyses of secondary outcomes (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>; <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a>; <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a>). </p> <p>For outcomes that included death we performed separate analyses for <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> which reported on deaths from randomisation at &lt; 72 hours and we combined results from <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> and <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a>. </p> <section id="CD002057-sec-0077"> <h4 class="title">1. Inhaled versus systemic steroids among infants ‐ outcomes including deaths (infants randomised at &lt; 72 hours of age) </h4> <p>Because only <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> was included in these analyses, tests for heterogeneity were not applicable. </p> </section> <section id="CD002057-sec-0078"> <h4 class="title">Primary outcome</h4> <section id="CD002057-sec-0079"> <h5 class="title">Death or BPD at 36 weeks' postmenstrual age</h5> <p>There was no statistically significant difference between the groups for the combined outcome of death or BPD at 36 weeks' postmenstrual age (RR 1.04, 95% CI 0.86 to 1.26; RD 0.03, 95% CI ‐0.09 to 0.14; 1 study, N = 292; <a href="./references#CD002057-fig-0004" title="">Analysis 1.1</a>; moderate‐quality evidence). </p> </section> </section> <section id="CD002057-sec-0080"> <h4 class="title">Secondary outcomes</h4> <section id="CD002057-sec-0081"> <h5 class="title">Death or BPD at 28 days of age</h5> <p>There was no statistically significant difference between the groups for the combined outcome of death or BPD at 28 days of age (RR 1.00, 95% CI 0.90 to 1.12; RD 0.00, 95% CI ‐0.09 to 0.09; 1 study, N = 292; <a href="./references#CD002057-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD002057-sec-0082"> <h5 class="title">Death at 36 weeks' postmenstrual age</h5> <p>There was no statistically significant effect on death at 36 weeks' postmenstrual age between groups (RR 0.96, 95% CI 0.62 to 1.49; RD ‐0.01, 95% CI ‐0.10 to 0.09; 1study, N = 292; <a href="./references#CD002057-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD002057-sec-0083"> <h5 class="title">Death at 28 days of age</h5> <p>No statistically significant effect on mortality by 28 days was noted between the groups (RR 0.85, 95% CI 0.52 to 1.37; RD ‐0.03, 95% CI ‐0.12 to 0.06; 1 study, N = 292; <a href="./references#CD002057-fig-0007" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD002057-sec-0084"> <h4 class="title">2. Inhaled versus systemic steroids among infants ‐ outcomes including deaths (infants randomised between 12 and 21 days of age) </h4> <p>Because only <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> was included in these analyses, tests for heterogeneity were not applicable. <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> did not report on deaths at 36 weeks' PMA or at 28 days of age. </p> </section> <section id="CD002057-sec-0085"> <h4 class="title">Primary outcome</h4> <section id="CD002057-sec-0086"> <h5 class="title">Death or BPD at 36 weeks' postmenstrual age</h5> <p>There was no statistically significant difference between groups for the combined outcome of death or BPD at 36 weeks' postmenstrual age (RR 0.94, 95% CI 0.83 to 1.05; RD ‐0.06, 95% CI ‐0.17 to 0.05; 1 study, N = 78; <a href="./references#CD002057-fig-0008" title="">Analysis 2.1</a>; low‐quality evidence). </p> </section> </section> <section id="CD002057-sec-0087"> <h4 class="title">Secondary outcomes</h4> <section id="CD002057-sec-0088"> <h5 class="title">Death at 36 weeks' postmenstrual age</h5> <p>There was no statistically significant effect on death at 36 weeks' postmenstrual age between groups (RR 2.69, 95% CI 0.13 to 54.15; RD 0.04, 95% CI ‐0.04 to 0.12; 1 study, N = 78; <a href="./references#CD002057-fig-0009" title="">Analysis 2.2</a>). </p> </section> <section id="CD002057-sec-0089"> <h5 class="title">Death at 28 days of age</h5> <p>No statistically significant effect on mortality by 28 days was noted between groups (RR 2.69, 95% CI 0.13 to 54.15; RD 0.04, 95% CI ‐0.04 to 0.12; 1 study, N = 78; <a href="./references#CD002057-fig-0010" title="">Analysis 2.3</a>). </p> </section> </section> <section id="CD002057-sec-0090"> <h4 class="title">3. Inhaled versus systemic steroids among infants ‐ secondary outcomes (infants randomised at &lt; 72 hours of age or between 12 and 21 days of age) </h4> </section> <section id="CD002057-sec-0091"> <h4 class="title">Secondary outcomes</h4> <section id="CD002057-sec-0092"> <h5 class="title">BPD at 36 weeks' postmenstrual age</h5> <p>There was no statistically significant difference in the incidence of BPD at 36 weeks' postmenstrual age in the inhaled steroid compared to systemic steroid group (typical RR 1.08, 95% CI 0.88 to 1.32; typical RD 0.03, 95% CI ‐0.06 to 0.12; 3 studies, N = 429; <a href="./references#CD002057-fig-0011" title="">Analysis 3.1</a>; low‐quality evidence). There was low heterogeneity for both RR (39%) and RD (28%). </p> </section> <section id="CD002057-sec-0093"> <h5 class="title">BPD at 28 days of age</h5> <p>There was no statistically significant difference in the incidence of BPD at 28 days between groups (typical RR 1.04, 95% CI 0.91 to 1.18; typical RD 0.03, 95% CI ‐0.06 to 0.12; 2 studies, N = 368; <a href="./references#CD002057-fig-0012" title="">Analysis 3.2</a>). There was low heterogeneity for both RR (46%) and RD (0 %). </p> </section> <section id="CD002057-sec-0094"> <h5 class="title">Need for ventilation amongst survivors at 36 weeks' postmenstrual age</h5> <p>There was no statistically significant difference for this outcome between groups (RR 1.10, 95% CI 0.30 to 4.06; RD 0.01, 95% CI ‐0.14 to 0.16; 1 study, N = 76; <a href="./references#CD002057-fig-0013" title="">Analysis 3.3</a>). </p> </section> <section id="CD002057-sec-0095"> <h5 class="title">Duration of mechanical ventilation among survivors (days)</h5> <p>The duration of mechanical ventilation was not statistically significantly different between groups (typical WMD ‐ 0.3 days, 95% CI ‐5.2 to 4.6; 2 studies, N = 368; <a href="./references#CD002057-fig-0014" title="">Analysis 3.4</a>). There was no heterogeneity for WMD (0%). </p> </section> <section id="CD002057-sec-0096"> <h5 class="title">Duration of supplemental oxygen among survivors (days)</h5> <p>The duration of supplemental oxygen was not statistically significantly different between groups (typical WMD ‐4.91 days, 95% CI ‐21 to 11; 2 studies, N = 368; <a href="./references#CD002057-fig-0015" title="">Analysis 3.5</a>). </p> </section> <section id="CD002057-sec-0097"> <h5 class="title">Length of hospital stay among survivors (days)</h5> <p>There was no statistically significant difference in the length of hospital stay among survivors between groups (MD ‐13, 95% CI ‐33 to 7; 1 study, N = 76; <a href="./references#CD002057-fig-0016" title="">Analysis 3.6</a>). Test for heterogeneity not applicable. </p> </section> <section id="CD002057-sec-0098"> <h5 class="title">Intraventricular haemorrhage grade III‐IV</h5> <p>There was no statistically significant difference in length of hospital stay among survivors between groups (RR 0.90, 95% CI 0.33 to 2.40; RD ‐0.03, 95% CI ‐0.28 to 0.23; 1 study, N = 61; <a href="./references#CD002057-fig-0017" title="">Analysis 3.7</a>). Test for heterogeneity not applicable. </p> </section> <section id="CD002057-sec-0099"> <h5 class="title">Periventricular leukomalacia</h5> <p>There was no statistically significant difference in the incidence of periventricular leukomalacia between groups (typical RR 0.85, 95% CI 0.34 to 2.13; typical RD ‐0.02, 95% CI ‐0.15 to 0.10; 2 studies, N = 137; <a href="./references#CD002057-fig-0018" title="">Analysis 3.8</a>). There was no heterogeneity for either RR (0%) or RD (0%). </p> </section> <section id="CD002057-sec-0100"> <h5 class="title">Hyperglycaemia</h5> <p>There was no statistically significant difference in the incidence of hyperglycaemia between groups (typical RR 0.86, 95% CI 0.61 to 1.22; typical RD ‐0.03, ‐0.11 to 0.05; 3 studies, N = 429; <a href="./references#CD002057-fig-0019" title="">Analysis 3.9</a>; low‐quality evidence). There was no heterogeneity for either RR (8%) or RD (0 %). </p> </section> <section id="CD002057-sec-0101"> <h5 class="title">Hypertension</h5> <p>There was no statistically significant difference in the incidence of hypertension between groups (typical RR 0.86, 95% CI 0.73 to 1.01; typical RD ‐0.08, 95% Ci ‐0.17 to 0.00; 3 studies, N = 429; <a href="./references#CD002057-fig-0020" title="">Analysis 3.10</a>; low‐quality evidence). There was no heterogeneity for either RR (0%) or RD (0%). </p> </section> <section id="CD002057-sec-0102"> <h5 class="title">Necrotising enterocolitis</h5> <p>There was no statistically significant difference in the incidence of necrotising enterocolitis between groups (typical RR 0.96, 95% CI 0.50 to 1.85; typical RD ‐0.00, 95% CI ‐0.06 to 0.06; 2 studies, N = 368; <a href="./references#CD002057-fig-0021" title="">Analysis 3.11</a>). There was no heterogeneity for either RR (0%) or RD (0%). </p> </section> <section id="CD002057-sec-0103"> <h5 class="title">Gastrointestinal bleed</h5> <p>There was no statistically significant difference in the incidence of gastrointestinal bleed between groups (typical RR 0.89, 95% CI 0.41 to 1.93; typical RD ‐0.01, 95% CI ‐0.06 to 0.04; 2 studies, N = 368; <a href="./references#CD002057-fig-0022" title="">Analysis 3.12</a>). As there were no outcomes in either group in one trial, test for heterogeneity for RR was not applicable. There was no heterogeneity for RD (0%). </p> </section> <section id="CD002057-sec-0104"> <h5 class="title">Retinopathy of prematurity ≥ stage 3</h5> <p>There was no statistically significant difference in the incidence of retinopathy of prematurity between groups (typical RR 1.32, 95% CI 0.77 to 2.25; typical RD 0.04, 95% CI ‐0.03 to 0.11; 3 studies, N = 363; <a href="./references#CD002057-fig-0023" title="">Analysis 3.13</a>). There was no heterogeneity for either RR (0%) or RD (0%). </p> </section> <section id="CD002057-sec-0105"> <h5 class="title">Culture‐proven sepsis</h5> <p>There was no statistically significant difference in the incidence of culture‐proven sepsis between groups (typical RR 1.07, 95% CI 0.79 to 1.45; RD 0.02, 95% CI ‐0.07 to 0.12; 2 studies, N = 368; <a href="./references#CD002057-fig-0024" title="">Analysis 3.14</a>). There was no heterogeneity for either RR (0%) or RD (0%). </p> </section> </section> <section id="CD002057-sec-0106"> <h4 class="title">Other outcomes</h4> <section id="CD002057-sec-0107"> <h5 class="title">Adrenocorticotropic hormone (ACTH) stimulation test</h5> <p><a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> reported that the ACTH test was completed for 24 infants. The baseline cortisol levels before the ACTH stimulation test for the 800 µg/d inhaled group (3 ± 2.3 µg/dL; N = 7) and the intravenous group (1.6 ± 1.3 µg/dL; N = 10) were statistically significantly lower than for the 400 µg/d inhaled group (7.3 ± 4.2 µg/dL; N = 7). However, the response to ACTH (i.e. relative rise in cortisol level) was similar in all three groups: 12 ± 5.7 µg/dL in the 400 µg/d inhaled group, 15.6 ± 8.5 µg/dL in the 800 µg/d inhaled group and 10.7 ± 4.6 µg/dL in the intravenous group, P = 0.408. Post ACTH stimulation cortisol levels were 18.4 ± 8.0 µg/dL in the 800 µg/d inhaled group, 19.3 ± 5.9 µg/dL in the 400 µg/d inhaled group and 12.3 ± 5.7 µg/dL in the intravenous group, P = 0.048. </p> <p>No relevant data for the following outcomes were available for analysis: measurement of pulmonary functions, growth at 36 week PMA, nephrocalcinosis, hypertrophy of tongue, cataract, pneumonia or hypertrophic cardiomyopathy. </p> </section> </section> <section id="CD002057-sec-0108"> <h4 class="title">4. Inhaled versus systemic steroids among children at 7 years of age (infants randomised at &lt; 72 hours of age) </h4> <p>A subset of infants enrolled in the OSECT study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>) were followed to a median age of 7 years. The study followed 127 (84%) of 152 survivors from the United Kingdom and Ireland. Of these, 75 children belonged to the late budesonide and late dexamethasone groups; 38 children belonged to the late budesonide group; and 37 children to the late dexamethasone group. </p> <p>Tests for heterogeneity were not applicable to any of these analyses because only one study was included in each analysis. </p> <p>There were no statistically significant differences between the early inhaled and the early systemic corticosteroid groups for the following outcomes in the <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> study which reported on 75 children. </p> <section id="CD002057-sec-0109"> <h5 class="title">General conceptual ability score at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids (MD ‐3.40, 95% CI ‐12.38 to 5.58; 1 study, N = 74; <a href="./references#CD002057-fig-0025" title="">Analysis 4.1</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0110"> <h5 class="title">Child Behaviour Checklist at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids (MD 0.20, 95% CI ‐4.75 to 5.15; 1 study, N = 74; <a href="./references#CD002057-fig-0026" title="">Analysis 4.2</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0111"> <h5 class="title">Strengths and Difficulties Questionnaire at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids, (MD 1.00, 95% CI ‐2.19 to 4.19; 1 study, N = 74; <a href="./references#CD002057-fig-0027" title="">Analysis 4.3</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0112"> <h5 class="title">Cerebral palsy at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids (RR 0.97, 95% CI 0.35 to 2.72; RD ‐0.01, 95% CI ‐0.18 to 0.17; 1 study, N = 69; <a href="./references#CD002057-fig-0028" title="">Analysis 4.4</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0113"> <h5 class="title">Moderate/severe disability at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids (RR 1.40, 95% CI 0.49 to 4.01; RD 0.05, 95% CI ‐0.11 to 0.22; 1 study, N = 74; <a href="./references#CD002057-fig-0029" title="">Analysis 4.5</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0114"> <h5 class="title">Death or moderate/severe disability at 7 years</h5> <p>There was no significant difference between the group who received inhaled steroids versus the group who received systemic steroids (RR 1.01, 95% CI 0.65 to 1.58; RD 0.00, 95% CI ‐0.18 to 0.19; 1 study, N = 107; <a href="./references#CD002057-fig-0030" title="">Analysis 4.6</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0115"> <h5 class="title">Systolic blood pressure &gt; 95th percentile at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids (RR 0.55, 95% CI 0.25 to 1.23; RD ‐0.16, 95% CI ‐0.36 to 0.05; 1 study, N = 70; <a href="./references#CD002057-fig-0031" title="">Analysis 4.7</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0116"> <h5 class="title">Diastolic blood pressure &gt; 95th percentile at 7 years</h5> <p>There was no significant difference between the groups of infants who received inhaled or systemic steroids (RR 1.38, 95% CI 0.43 to 4.45; RD 0.05, 95% CI ‐0.12 to 0.21; 1 study, N = 69; <a href="./references#CD002057-fig-0032" title="">Analysis 4.8</a>; moderate‐quality evidence). </p> </section> <section id="CD002057-sec-0117"> <h5 class="title">Ever diagnosed with asthma by 7 years</h5> <p>There was no significant difference between the groups who received inhaled or systemic steroids (RR 0.87, 95% CI 0.55 to 1.39; RD ‐0.07, 95% CI ‐0.30 to 0.16; 1 study, N = 73; <a href="./references#CD002057-fig-0033" title="">Analysis 4.9</a>; moderate‐quality evidence). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002057-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002057-sec-0118">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002057-sec-0177">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002057-sec-0118"></div> <section id="CD002057-sec-0119"> <h3 class="title" id="CD002057-sec-0119">Summary of main results</h3> <p>We included three studies that involved a total of 431 infants.</p> <p>Evidence from two studies in 370 infants contributing data to the primary outcome of this review showed that inhaled steroids administered after 7 days of age compared with systemic steroids did not decrease the incidence of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age. </p> <p>Evidence from three studies in 431 infants contributing to secondary outcomes showed that inhaled steroids administered after seven days of age compared with systemic steroids did not significantly alter the incidence of BPD at 36 weeks' postmenstrual age, hyperglycaemia, hypertension, duration of ventilation, duration of oxygen supplementation, length of hospital stay, intraventricular haemorrhage grade III‐IV, periventricular leukomalacia, necrotising enterocolitis, gastrointestinal bleed, retinopathy of prematurity stage &gt; 3, culture‐proven sepsis or the incidence of adverse effects. </p> <p>One study received grant support and the industry provided Aerochambers and metered dose inhalers of budesonide and placebo for the same study. No conflict of interest was identified. </p> </section> <section id="CD002057-sec-0120"> <h3 class="title" id="CD002057-sec-0120">Overall completeness and applicability of evidence</h3> <p>For the primary outcome death or BPD at 36 weeks' postmenstrual age data from <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> were reported separately as they randomised infants &lt; 72 hours of age. <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> reported on the primary outcome but enrolled infants between 12 to 21 days of age. <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> did not report on the primary outcome. Data from three trials (<a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a>; <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a>) were combined for secondary outcomes as treatment started in infants &gt; 7 days old. The period of measurement of outcomes varied between <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> and <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> making combination of results inappropriate. This may possibly explain differences in the incidence of adverse events such as mortality. <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> counted deaths from &lt; 72 hours onwards and <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> counted deaths from 12 to 21 days onwards. This means that in <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>, all deaths &lt; 72 hours were attributed to the randomised treatment policy, whereas in <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a>, only deaths from 12 to 21 days were so attributed. Looking at the control event rate we see what we would expect ‐ a much higher death rate in <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> than in <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> (death at 36 weeks' was 33/150 in <a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a> and 0/27 in <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a>). Similar explanations could be provided for the other outcomes of interest. Due to these concerns, aggregation of data from the two trials was not performed when outcomes included deaths. </p> </section> <section id="CD002057-sec-0121"> <h3 class="title" id="CD002057-sec-0121">Quality of the evidence</h3> <p>According to GRADE assessment of the quality of the evidence for the outcome of death or BPD at 36 weeks' postmenstrual age (primary outcome) for infants randomised at &lt; 72 hours of age was moderate (<a href="./full#CD002057-tbl-0001">summary of findings Table for the main comparison</a>). The quality of the evidence according to GRADE for the outcome of death or BPD at 36 weeks' postmenstrual age (primary outcome) for infants randomised between 12 to 21 days of age was low (<a href="./full#CD002057-tbl-0002">summary of findings Table 2</a>). </p> <p>For secondary outcomes we included for infants randomised at &lt; 72 hours or between 12 and 21 days: BPD at 36 weeks' postmenstrual age, hyperglycaemia, and hypertension. The quality of the evidence according to GRADE was low (<a href="./full#CD002057-tbl-0003">summary of findings Table 3</a>). For infants randomised at &lt; 72 hours of age we included in GRADE assessments the following outcomes at seven years of age: general conceptual ability; moderate/severe disability; death or moderate/severe disability; systolic blood pressure &gt; 95th percentile; diastolic blood pressure &gt; 95th percentile and ever diagnosed with asthma. According to GRADE the quality of the evidence was moderate for these outcomes (<a href="./full#CD002057-tbl-0004">summary of findings Table 4</a>). </p> </section> <section id="CD002057-sec-0122"> <h3 class="title" id="CD002057-sec-0122">Potential biases in the review process</h3> <p>We are not aware of any potential biases in our review process. One author (HH) is the first author of an included trial (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). That study was assessed by the other three authors (AO, SS, VS). </p> </section> <section id="CD002057-sec-0123"> <h3 class="title" id="CD002057-sec-0123">Agreements and disagreements with other studies or reviews</h3> <p>We found no evidence that inhaled steroids confer any net advantages over systemic steroids in the management of ventilator‐dependent preterm infants. Systemic steroids given late (after 1 week) suggest that late therapy may reduce neonatal mortality without significantly increasing the risk of adverse long‐term neurodevelopmental outcomes (<a href="./references#CD002057-bbs2-0017" title="DoyleLW , HallidayHL , EhrencranzRA . Late (&gt; 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001145.pub3] ">Doyle 2014a</a>; <a href="./references#CD002057-bbs2-0046" title="ShahV , OhlssonA . Postnatal dexamethasone in the prevention of chronic lung disease. In: DavidTJ editor(s). Recent Advances in Paediatrics. London, England: Churchill Livingstone, 2001:77‐96. ">Shah 2001</a>). However, systemic steroids, especially dexamethasone given early (&lt; 7 days of age), are associated with an increase in abnormal neurological exam findings and cerebral palsy (<a href="./references#CD002057-bbs2-0016" title="DoyleLW , HallidayHL , EhrenkranzRA . Early (&lt; 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001146.pub4] ">Doyle 2014</a>). Further studies with particular attention on long‐term neurodevelopmental outcomes need to be performed before delayed steroids, either inhaled or systemic, can be confirmed as safe for treatment of evolving BPD in preterm infants. Follow‐up studies are extremely important. A subset of surviving infants from the OSECT study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>) have been followed to seven years of age and the results are included in this updated review. </p> <p>A major concern with studies of inhaled steroid therapy is uncertainty regarding drug delivery and deposition of steroids in the oropharynx and peripheral airways. Numerous factors affect drug delivery and deposition including numbers of particles in the respirable range, delivery technique (use of a metered dose inhaler with or without a spacer), nebuliser (jet or ultrasonic) and the presence or absence of an endotracheal tube. Previous reports have shown that the amount of aerosol delivery varies from 0.4% to 14% based on the technique used (<a href="./references#CD002057-bbs2-0007" title="ArnonS , GriggJ , NikanderK , SilvermanM . Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Pediatric Pulmonology1992;13(3):172‐5. ">Arnon 1992</a>; <a href="./references#CD002057-bbs2-0020" title="GriggJ , ArnonS , JonesT , ClarkeA , SilvermanM . Delivery of therapeutic aerosols to intubated babies. Archives of Disease in Childhood1992;67(1 Spec No):25‐30. ">Grigg 1992</a>; <a href="./references#CD002057-bbs2-0036" title="O'CallaghanC , HardyJ , StammersJ , StephensenT , HullD . Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Archives of Disease in Childhood1992;67(1 Spec No):20‐4. ">O'Callaghan 1992</a>). The delayed onset of activity (<a href="./references#CD002057-bbs2-0004" title="DimitriouG , GreenhoughA , GiffinFJ , KavadiaV . Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. European Journal of Pediatrics1997;156(1):51‐5. ">Dimitriou 1997</a>) and a similar risk profile of inhaled steroids (<a href="./references#CD002057-bbs2-0048" title="ShahVS , OhlssonA , HallidayHL , DunnM . Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD001969.pub4] ">Shah 2017</a>) suggests that effects may be secondary to systemic absorption. </p> <p>Inhaled steroids are believed to be less effective compared to systemic steroids. The drug type, dosage and delivery methods may be inadequate. More refinements in the inhalational drug delivery system guaranteeing selective delivery in the alveoli and smaller airways may improve the clinical efficacy and decrease the side effect profile of inhaled steroids. </p> <p>In the present review, there is no evidence of difference in effectiveness or side effect profiles for inhaled versus systemic steroids. A better delivery system or higher dose of inhaled steroids may result in equivalence of effectiveness for the two modes of administration, but may also show evidence of side effects. To resolve this issue, studies are needed to identify the risk/benefit ratio of different delivery techniques and dosing schedules for the administration of these medications. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD002057-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram: review update" data-id="CD002057-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD002057-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD002057-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 1 Death or BPD at 36 weeks' postmenstrual age." data-id="CD002057-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 1 Death or BPD at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 2 Death or BPD at 28 days of age." data-id="CD002057-fig-0005" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 2 Death or BPD at 28 days of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 3 Death at 36 weeks' postmenstrual age." data-id="CD002057-fig-0006" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 3 Death at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 4 Death at 28 days of age." data-id="CD002057-fig-0007" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h), Outcome 4 Death at 28 days of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age), Outcome 1 Death or BPD at 36 weeks' postmenstrual age." data-id="CD002057-fig-0008" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age), Outcome 1 Death or BPD at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age), Outcome 2 Death at 36 weeks' postmenstrual age." data-id="CD002057-fig-0009" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age), Outcome 2 Death at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age), Outcome 3 Death at 28 days of age." data-id="CD002057-fig-0010" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age), Outcome 3 Death at 28 days of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 1 BPD at 36 weeks' postmenstrual age." data-id="CD002057-fig-0011" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 1 BPD at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 2 BPD at 28 days of age." data-id="CD002057-fig-0012" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 2 BPD at 28 days of age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 3 Need for ventilation among survivors at 36 weeks' postmenstrual age." data-id="CD002057-fig-0013" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 3 Need for ventilation among survivors at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 4 Duration of mechanical ventilation among survivors (days)." data-id="CD002057-fig-0014" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 4 Duration of mechanical ventilation among survivors (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 5 Duration of supplemental oxygen among survivors (days)." data-id="CD002057-fig-0015" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 5 Duration of supplemental oxygen among survivors (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 6 Length of hospital stay among survivors (days)." data-id="CD002057-fig-0016" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 6 Length of hospital stay among survivors (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 7 Intraventricular haemorrhage grade III‐IV." data-id="CD002057-fig-0017" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 7 Intraventricular haemorrhage grade III‐IV. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 8 Periventricular leukomalacia." data-id="CD002057-fig-0018" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 8 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 9 Hyperglycaemia." data-id="CD002057-fig-0019" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 9 Hyperglycaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 10 Hypertension." data-id="CD002057-fig-0020" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 10 Hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 11 Necrotising enterocolitis." data-id="CD002057-fig-0021" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 11 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 12 Gastrointestional bleed." data-id="CD002057-fig-0022" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 12 Gastrointestional bleed. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 13 Retinopathy of prematurity ≥ stage 3." data-id="CD002057-fig-0023" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 13 Retinopathy of prematurity ≥ stage 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 14 Culture‐proven sepsis." data-id="CD002057-fig-0024" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age), Outcome 14 Culture‐proven sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 1 General conceptual ability (GCA) score at 7 years." data-id="CD002057-fig-0025" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 1 General conceptual ability (GCA) score at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 2 Child behaviour check list (CBLC) at 7 years." data-id="CD002057-fig-0026" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 2 Child behaviour check list (CBLC) at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 3 Strengths and Difficulties Questionnaire (SDQ) at 7 years." data-id="CD002057-fig-0027" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 3 Strengths and Difficulties Questionnaire (SDQ) at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 4 Cerebral palsy at 7 years." data-id="CD002057-fig-0028" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 4 Cerebral palsy at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 5 Moderate/severe disability at 7 years." data-id="CD002057-fig-0029" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 5 Moderate/severe disability at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 6 Death or moderate/severe disability at 7 years." data-id="CD002057-fig-0030" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 6 Death or moderate/severe disability at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 7 Systolic blood pressure of &gt; 95th percentile at 7 years." data-id="CD002057-fig-0031" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 7 Systolic blood pressure of &gt; 95th percentile at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 8 Diastolic blood pressure of &gt; 95th percentile at 7 years." data-id="CD002057-fig-0032" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 8 Diastolic blood pressure of &gt; 95th percentile at 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002057-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/urn:x-wiley:14651858:media:CD002057:CD002057-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_t/tCD002057-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 9 Ever diagnosed as asthmatic by 7 years." data-id="CD002057-fig-0033" src="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours), Outcome 9 Ever diagnosed as asthmatic by 7 years. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/media/CDSR/CD002057/image_n/nCD002057-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD002057-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> Neonatal intensive care unit </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death or BPD at 36 weeks' postmenstrual age</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.04 (95% CI 0.86 to 1.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>292 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for this single study was high. The study was not blinded at all sites. Only 35/150 infants randomised to systemic steroids received full course while 33/142 infants randomised to inhaled steroids received full course. Results were presented in intention to treat analyses including deaths occurring after 72 hours of age. We downgraded the quality of the evidence by one step.<br/> Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was acceptable</p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>606 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD</b> : Bronchopulmonary dysplasia; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours of age)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD002057-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised between 12 and 21 days of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD (infants randomised between 12 and 21 days of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> Neonatal intensive care unit </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death or BPD at 36 weeks'</b> postmenstrual age </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94 (95% CI 0.83 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>78 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for this single study was high. There was no blinding of the intervention or outcome measurements. We downgraded the quality of the evidence by one level.<br/> Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was low as the sample size was small</p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>963 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>902 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD:</b> Bronchopulmonary dysplasia; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised between 12 and 21 days of age)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD002057-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> Neonatal intensive care unit </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>BPD at 36 weeks'</b> postmenstrual age </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.08 (95% CI 0.88 to 1.32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>429 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for these three studies was high. There was blinding of randomisation in all three studies. There was no blinding of the intervention or outcome measurements at all sites in the largest study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> there was blinding of the intervention but blinding of outcome assessment was unclear. In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> there was no blinding of the intervention or outcomes measurements. We downgraded the quality of the evidence by two levels.<br/> Heterogeneity/consistency: Heterogeneity was low (I² = 39%).<br/> Directness of the evidence: The studies were conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was high as the sample size was quite large. </p> <p>Presence of publication bias: N/A. We did not create a funnel plot as there were only three trials included in the analysis. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>422 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>485 per 1000<br/> (394 to 776) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hyperglycaemia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86 (95% CI 0.61 to 1.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>429 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for these three studies was high. There was blinding of randomisation in all three studies. There was no blinding of the intervention or outcome measurements at all sites in the largest study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> there was blinding of the intervention but blinding of outcome assessments was unclear. In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> there was no blinding of the intervention or outcome measurements. We downgraded the quality of the evidence by two levels. </p> <p>Heterogeneity/consistency: There was no heterogeneity (I² = 8%).<br/> Directness of the evidence: The studies were conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was high as the sample size was quite large. </p> <p>Presence of publication bias: N/A. We did not create a funnel plot as there were only three trials included in the analysis. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>177 per 1000<br/> (0 to 282) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Hypertension</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>High risk population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR (RR 0.86, 95% CI 0.73 to 1.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>429 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Bias: The risk of bias for these three studies was high. There was blinding of randomisation in all three studies. There was no blinding of the intervention or outcome measurements at all sites in the largest study (<a href="./references#CD002057-bbs2-0001" title="HallidayHL , PattersonCC , HalahakoonCW , European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics2001;107(2):232‐40. WilsonTT . Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over‐looked Factor? [PhD thesis]. Belfast (UK): Queen’s University Belfast, 2005. WilsonTT , WatersL , PattersonCC , McCuskerCG , RooneyNM , MarlowN , et al. Neurodevelopmental and respiratory follow‐up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics2006;117(6):2196‐205. ">Halliday 2001</a>). In <a href="./references#CD002057-bbs2-0002" title="RozyckiHJ , ByronPR , ElliottGR , CarrollT , GutcherGR . Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology2003;35(5):375‐83. ">Rozycki 2003</a> there was blinding of the intervention but blinding of outcome assessments was unclear. In <a href="./references#CD002057-bbs2-0003" title="SuchomskiSJ , CummingsJJ . A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology2002;22(3):196‐203. ">Suchomski 2002</a> there was no blinding of the intervention or outcome measurements. We downgraded the quality of the evidence by two steps. </p> <p>Heterogeneity/consistency: There was no heterogeneity (I² = 0%).<br/> Directness of the evidence: The studies were conducted in the target population of newborn infants. </p> <p>Precision: The precision for the point estimate was high as the sample size was quite large. </p> <p>Presence of publication bias: N/A. We did not create a funnel plot as there were only three trials included in the analysis. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>604 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>430 per 1000<br/> (130 to 627) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD:</b> Bronchopulmonary dysplasia; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD002057-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD ‐ long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours of age)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhaled steroids compared with systemic steroids for BPD ‐ long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours of age)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Neonates with developing BPD </p> <p><b>Settings:</b> NICU </p> <p><b>Intervention:</b> Inhaled steroids </p> <p><b>Comparison:</b> Systemic steroids </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Systemic steroids</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhaled steroids</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General conceptual ability (GCA) score at 7 years</b> </p> <p>The test has a standardisation mean of 100 and SD of 15</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean GCA score in the control group was 90.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean GCA score in the intervention groups was 3.4 units lower</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐3.40 (95% CI ‐12.38 to 5.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the Quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Moderate/severe disability at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>135 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.40 (95% CI 0.49 to 4.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the Quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or moderate/severe disability at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>418 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>423 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.01 (95% CI 0.65 to 1.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>107 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the Quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Systolic blood pressure &gt; 95th percentile at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>353 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>194 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.55 (95% CI 0.25 to 1.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Diastolic blood pressure &gt; 95th percentile at 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>121 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>167 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR (1.38, 95% CI 0.43 to 4.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ever diagnosed as asthmatic by 7 years</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>528 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>459 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.87 (95% CI 0.55 to 1.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bias: The risk of bias for this outcome was low. This outcome was reported in a subset of infants, who had been enrolled in the trial in Ireland and the UK. The assessors of all the long‐term outcomes were blinded to the original treatment group allocation. </p> <p>Heterogeneity/consistency: Heterogeneity was N/A as there was only one study included in the analysis.<br/> Directness of the evidence: The study was conducted in the target population of newborn infants. </p> <p>Precision: Precison for the point estimate was low because of the small sample size. We downgraded the quality of the evidence by one step. </p> <p>Presence of publication bias: N/A.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>BPD:</b> Bronchopulmonary dysplasia; <b>NICU:</b> Neonatal intensive care unit; <b>N/A</b>: Not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Inhaled steroids compared with systemic steroids for BPD ‐ long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours of age)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/full#CD002057-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002057-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death or BPD at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.86, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death or BPD at 28 days of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.90, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.62, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Death at 28 days of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.52, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inhaled versus systemic steroids among all randomised infants ‐ outcomes including deaths (infants randomised at &lt; 72 h)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002057-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death or BPD at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.83, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.69 [0.13, 54.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death at 28 days of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.69 [0.13, 54.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inhaled versus systemic steroids among infants ‐ outcomes including deaths (Infants randomised between 12 and 21 days of age)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002057-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 BPD at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.88, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 BPD at 28 days of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Need for ventilation among survivors at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.30, 4.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of mechanical ventilation among survivors (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐5.22, 4.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Duration of supplemental oxygen among survivors (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.91 [‐20.87, 11.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Length of hospital stay among survivors (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.0 [‐33.22, 7.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Intraventricular haemorrhage grade III‐IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.33, 2.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.34, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Hyperglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.61, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.73, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.50, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Gastrointestional bleed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.41, 1.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Retinopathy of prematurity ≥ stage 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.77, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Culture‐proven sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.79, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Inhaled versus systemic steroids ‐ secondary outcomes (infants randomised at &lt; 72 hours or between 12 and 21 days of age)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002057-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 General conceptual ability (GCA) score at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐12.38, 5.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Child behaviour check list (CBLC) at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐4.75, 5.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Strengths and Difficulties Questionnaire (SDQ) at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [‐2.19, 4.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cerebral palsy at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.35, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Moderate/severe disability at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [0.49, 4.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Death or moderate/severe disability at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.65, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Systolic blood pressure of &gt; 95th percentile at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.25, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Diastolic blood pressure of &gt; 95th percentile at 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.43, 4.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Ever diagnosed as asthmatic by 7 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.55, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Inhaled versus systemic steroids ‐long‐term outcomes at 7 years of age (infants randomised at &lt; 72 hours)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002057.pub4/references#CD002057-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002057.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD002057-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002057-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD002057-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD002057-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD002057-note-0004">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002057\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002057\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002057\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002057\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002057\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002057.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002057.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002057.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002057.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002057.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726807097"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002057.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726807101"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002057.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9ca87b1af480',t:'MTc0MDcyNjgwNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 